noticeable effect is the increase in the mean number of days of bleeding and spotting in 30 day intervals, with about 25% 4 To whom correspondence should be addressed of users having more than 10 days of bleeding and spotting The relationship between ovarian hormones and bleeding in each month (Díaz et al., 1995) .
patterns during continuous progestin contraception was
Administration of exogenous oestrogen or in combination studied in 29 women who used Nestorone ® (NES) releasing with a progestin is known to reduce bleeding in women using implants. Oestradiol and progesterone were measured in Norplant ® implants (Díaz et al., 1990 ; Alvarez-Sanchez et al., blood samples taken twice a week for 6 consecutive weeks, 1996; Archer et al., 1996) . The association between concentraduring months 6, 12, 18 and 24 of implant use. Retrospecttions of endogenous oestrogen and bleeding during the use of ively, the association between hormonal concentrations and Norplant ® implants has also been established, and serves as bleeding patterns was evaluated. Twenty-four short (≤ 24 the basis for treatment with ethinyl-oestradiol (Faúndes et al., days), 36 normal (25-35 days), 27 long (36-90 days) and 1991, 1998) . The present study was undertaken to ascertain nine episodes of amenorrhoea, as well as 28 periods of whether this association between concentrations of endogenous prolonged bleeding, were identified. Short cycles, periods sex steroids and bleeding patterns exists in women who are of prolonged bleeding and amenorrhoea were characterized NES implant users. by low oestradiol concentrations. Bleeding after a normal or long cycle regularly occurred after a rise and fall of oestradiol or oestradiol and progesterone. New progestins with different metabolic profiles and other maintain a daily bleeding calendar. Ten subjects were dropped from attributes are being employed in the development of new the study for bleeding disturbances or other complaints during the subdermal implant systems for contraception in women first months of use and another was unable to comply with the bloodsampling schedule. Consequently, only 29 subjects provided the (Alvarez-Sanchez et al., 1993; Ladipo and Coutinho, 1994 In each sample, oestradiol and progesterone were measured using a solid-phase 125 I radioimmunoassay (DPC, Los Angeles, CA, USA). Inter-assay coefficients of variation were 6.52 and 6.06% respectively. Nestorone ® is the registered trademark of the Population Council for 16-methylene-17α-acetoxy-19-nor-progesterone.
Quality control was assured both by the External Quality Assessment
Scheme for Reproductive Hormones of the World Health Organization and by internal quality control with commercial sera. The oestradiol and progesterone patterns that preceded bleeding episodes or that corresponded to periods of continuous bleeding or amenorrhoea were analysed retrospectively. Data were collected from 15 and 14 subjects in the low and high dose regimen, respectively. For this study, the data were analysed jointly, because its purpose was to test the possible association between different concentrations of endogenous hormones and bleeding, and not to compare the two systems. As more than one bleeding episode was observed in many subjects, data were obtained in a total of 125 bleeding episodes.
Bleeding periods were categorized as follows: normal length cycles (25-35 days); long cycles (36-90 days); episodes of amenorrhoea longer than 90 days; and short cycles (24 days or less between initiation of two consecutive bleedings). The association between the duration of bleeding (in days) and the preceding hormonal profile was separately analysed as well as the periods of continuous bleeding or spotting for 10 or more days.
Upon evaluation of the available hormonal data related to the bleeding patterns, it was possible to analyse 24 short cycles, 36 normal length cycles, 27 long cycles and nine episodes of amenorrhoea. Blood Figure 1 . Oestradiol serum concentrations preceding bleeding in samples were collected only in the middle of an amenorrhoeic episode different menstrual patterns.
in four subjects, only during the last 3 weeks in three women and before and during the last 3 weeks in two. Twenty-eight episodes of prolonged bleeding were separately analysed.
Most of the episodes with amenorrhoea were observed during the first 6 months of use. Short cycles and prolonged bleeding were mostly seen during the first year, while normal length and long cycles were more evenly distributed over the 2 years of observation, although less frequently during the first 6 months of use of the implants.
Student's t-test was used to evaluate differences in duration of bleeding, and in hormonal concentrations. The correlation coefficient between oestradiol concentrations and duration of bleeding was calculated and a t-test was used to verify its significance.
Results

Hormonal patterns and cycle length
Short cycles were characterized by low oestradiol concentra- tions, below 350 pmol/l and even less than 175 pmol/l, with the exception of three out of 24 cycles that had samples with oestradiol concentration above 350 pmol/l. No luteal activity was observed in this group (Table I) . periods of amenorrhoea. a Significantly different from the other two groups (P ϭ 0.0000). b Significantly different from short cycles with no luteal activity (P ϭ 0.0002); normal or long cycles with luteal activity (P ϭ 0.0016).
Oestradiol concentrations preceding menses
The hormonal patterns of women with normal length cycles with or without luteal activity, and with long cycles, were characterized by a rise and fall of oestradiol that preceded bleeding. In contrast, in women with short cycles, bleeding started without discernible change in constantly low oestradiol concentrations (Figure 1 ). The oestradiol profile was monophasic in long cycles or normal cycles without luteal activity and biphasic in normal length cycles with luteal activity.
Duration of bleeding
The duration of bleeding was directly and significantly associated with the highest concentrations of oestradiol observed during the 15 days preceding menses in episodes without luteal activity (r ϭ 0.4007, P ϭ 0.0002) (Figure 2 ). There were three clear outliers: one with a prolonged bleeding episode pmol/l, and two others with relatively short bleeding episodes (5 and 7 days) after very high oestradiol concentrations above 3 days before and the 3 days after the bleeding episode. The 3500 pmol/l. The correlation was greatly improved (r ϭ initiation and termination of a prolonged bleeding episode 0.6371, P ϭ 0.0000) when these outliers were excluded from were associated with a pattern of decreasing and increasing the analyses.
concentrations of oestradiol respectively. The oestradiol conMean duration of bleeding in normal or long length cycles, centration in the intermediate part of a prolonged bleeding without luteal activity, was significantly longer (P ϭ 0.0016) was significantly lower than just before the initiation of the than the duration of bleeding episodes that followed normal episode (P ϭ 0.0000), than in the initial 3 days of bleeding or long cycles with luteal activity (Table II) . This association (P ϭ 0.0047) and than the concentrations just after bleeding remained when comparing 14 episodes that could be matched stopped (P ϭ 0.03). Three of 21 of these episodes, in which by oestradiol concentrations. The mean number of bleeding there were samples for evaluation, did not show this pattern days after a bleeding-free interval without a rise in progesterone at initiation of bleeding. The picture was not as clear at the was 9.0 Ϯ 4.7, versus 5.4 Ϯ 1.4 days after intervals with a end of a bleeding episode. Eight of 19 cycles (42%) did not rise in serum progesterone over 8.0 nmol/l.
show this pattern, although the mean oestradiol of the samples taken in the first 3 days of the following bleeding free interval Episodes of prolonged bleeding was significantly higher than during the mid part of the Prolonged bleeding generally corresponded to periods of relableeding episode. tively low serum oestradiol after high oestradiol concentrations without luteal activity. For the analyses of this process, Discussion prolonged bleeding episodes were divided into three periods: the first 3 days, an intermediate period, and the last 3 days of
The results of this study suggest that the ovarian secretion of oestradiol and progesterone during use of NES releasing bleeding. Figure 3 shows the mean oestradiol concentrations in each of these three periods, as well as in samples taken the implants influences the menstrual pattern of the users. Almost every woman with cycles of normal length, as well as most theory, based on the results presented here, it would be possible to obtain similar results. of those with long cycles, had oestradiol secretion indicative
The mechanism through which sex steroids affect endometof follicular development and a rise and fall of oestradiol rial bleeding is very poorly understood. Apparently, it is not preceded bleeding.
necessarily accompanied by a parallel change in endometrial The finding that the higher the oestradiol concentrations in histology (Kim-Bjorkland, 1991; Landgren et al., 1994) or of a cycle, the longer the duration of bleeding and that the endometrial thickness as measured by ultrasound (Olsson et al. , secretion of progesterone is associated with shorter duration 1990; Shaaban et al., 1993; Faúndes et al., 1998) . It may be of bleeding provides additional evidence in support of the more related to changes in the vascular physiology of the hypothesis that, in spite of the continuous administration of endometrium as suggested by others (Rogers et al., 1993 ; NES, endogenous hormones have some influence over the Goodger et al., 1994; Hickey et al., 1998) . Nonetheless, endometrium and the mechanism that controls its bleeding.
independently of the intervention of other factors and of The results also indicate that the relationship between the intimate mechanism of action, the accumulated evidence endogenous sexual hormones and bleeding is not present in strongly suggests that female sex steroids continue to play a all cases, and that bleeding can start or stop without clear major role in endometrium bleeding control among women changes in the oestradiol concentrations. Persistently low under continuous administration of low doses of contraceptive oestradiol concentrations can coincide with long episodes of progestogens. amenorrhoea, short cycles and periods of prolonged bleeding. Many times the initiation and the end of short cycles and bleeding episodes after amenorrhoea do not coincide with Acknowledgements discernible changes in oestradiol concentrations. This finding (Darney et al., 1996; Fraser et al., 1996) . Nations Fund for Populations Activities is gratefully acknowledged.
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